Observational studyJournal of the American Heart Association2020
Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era.
Observational study in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 51 citations in OpenAlex.
- A Randomized Trial Evaluating Automated Notifications for the Identification and Treatment of Aortic Stenosis and Mitral Regurgitation: The ALERT Study.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Article
- Contemporary Resource Use and Costs Among Patients With Medically Managed Severe Aortic Stenosis: Results From a US National Claims Database.Journal of the American Heart Association · 2025Article
- Global, regional, and national burden of nonrheumatic calcific aortic valve disease based on GBD study 2021.Scientific reports · 2025Article
- Racial and ethnic disparities in aortic stenosis within a universal healthcare system characterized by natural language processing for targeted intervention.European heart journal. Digital health · 2025Article
- Insurance-based Disparities in Outcomes and Extracorporeal Membrane Oxygenation Utilization for Hospitalized COVID-19 Patients.Anesthesiology · 2024Article
- Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases.Journal of the National Medical Association · 2024Article
- Racial/Ethnic Disparities in Aortic Valve Replacement Among Medicare Beneficiaries in the United States, 2012-2019.The American journal of medicine · 2024Article
- Unequal Treatment and Yentl Syndrome: Are We Providing Appropriate Care for Our TAVR Patients?JACC. Asia · 2024Article
- Limited Access to Aortic Valve Procedures in Socioeconomically Disadvantaged Areas.Journal of the American Heart Association · 2024Article
- Racial and Ethnic Disparities in Peri-and Post-operative Cardiac Surgery.Current cardiovascular risk reports · 2024Review
- Racial disparities in TAVR outcomes in patients with cancer.Frontiers in cardiovascular medicine · 2024Article
- Article
- Comorbidities and Symptom Status in Moderate and Severe Aortic Stenosis: A Multicenter Clinical Cohort Study.JACC. Advances · 2023Article
- Racial and ethnic disparities in diagnosis, management and outcomes of aortic stenosis in the Medicare population.PloS one · 2023Article
- Racial and Ethnic Disparities in Aortic Stenosis.Journal of the American Heart Association · 2022Article
- Racial and Ethnic Differences in the Clinical Diagnosis of Aortic Stenosis.Journal of the American Heart Association · 2022Article
- Racial and Ethnic Disparities in Access to Minimally Invasive Mitral Valve Surgery.JAMA network open · 2022Article
- Counting the cost of premature mortality with progressively worse aortic stenosis in Australia: a clinical cohort study.The lancet. Healthy longevity · 2022Observational
- Impact of Managing Provider Type on Severe Aortic Stenosis Management and Mortality.Journal of the American Heart Association · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 1 country.
Funding
Abstract
Background Aortic valve replacement (AVR) is a life-saving treatment for patients with symptomatic severe aortic valve stenosis. We sought to determine whether transcatheter AVR has resulted in a more equitable treatment rate by race in the United States. Methods and Results A total of 32 853 patients with symptomatic severe aortic valve stenosis were retrospectively identified via Optum's deidentified electronic health records database (2007-2017). AVR rates in non-Hispanic Black and White patients were assessed in the year after diagnosis. Multivariate Fine-Gray hazards models were used to evaluate the likelihood of AVR by race, with adjustment for patient factors and the managing cardiologist. Time-trend and 1-year symptomatic severe aortic valve stenosis survival analyses were also performed. From 2011 to 2016, the rate of AVR increased from 20.1% to 37.1%. Overall, Black individuals were less likely than Whites to receive AVR (22.9% versus 31.0%; unadjusted hazard ratio [HR], 0.70; 95% CI, 0.62-0.79; fully adjusted HR, 0.76; 95% CI, 0.67-0.85). Yet, during 2015 to 2016, AVR racial differences were attenuated (29.5% versus 35.2%; adjusted HR, 0.86; 95% CI, 0.74-1.02) because of greater uptake of transcatheter AVR in Blacks than Whites (53.4% of AVRs versus 47.3%;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.